Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

Feb 26 (Reuters) - Eli Lilly's experimental weight-loss pill, orforglipron, caused more side effects and treatment ...

Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be available this spring.

Orforglipron, which could be approved for obesity next quarter, proved superior at cutting blood sugar and body weight — but at the expense of higher side effect rates.

A major new clinical trial involving more than 1,600 people has found that a GLP-1 pill form of the drug orforglipron works about as well as injectable semaglutide for people with type 2 diabetes.

Orforglipron carried more side effects, however ...

Women with type 2 diabetes who started on metformin rather than a sulfonylurea had roughly 30 percent lower odds of dying before age 90, according to a new study built on decades of data from the ...

A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 ...

Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, ...

A pill already on the market might help slow progression of type 1 diabetes Baricitinib taken daily preserved people’s insulin production and stabilized their blood sugar The pill is already approved ...

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage—not by controlling blood sugar as originally ...

Lifestyle Changes for Diabetes: Diabetes affects a large population worldwide. India also has a significant number of patients. Let us explain whether it is possible to stop taking medication. Do I ...